Outcomes in Patients With COVID-19 Disease and High Oxygen Requirements.
COVID-19 disease
Critically ill
High oxygen requirement
SARS-CoV-2
Journal
Journal of clinical medicine research
ISSN: 1918-3003
Titre abrégé: J Clin Med Res
Pays: Canada
ID NLM: 101538301
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
10
12
2020
accepted:
21
12
2020
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
ppublish
Résumé
Approximately 19% of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) progress to severe or critical stages of the coronavirus disease 2019 (COVID-19) with a mortality rate exceeding 50%. We aimed to examine the characteristics, mortality rates, intubation rate, and length of stay (LOS) of patients hospitalized with COVID-19 disease with high oxygen requirements (critically ill). We conducted a retrospective analysis in a single center in Brooklyn, New York. Adult hospitalized patients with confirmed COVID-19 disease and high oxygen requirements were included. We performed multivariate logistic regression analyses for statistically significant variables to reduce any confounding. A total of 398 patients were identified between March 19th and April 25th, 2020 who met the inclusion criteria, of which 247 (62.1%) required intubation. The overall mortality rate in our study was 57.3% (n = 228). The mean hospital LOS was 19.1 ± 17.4 days. Patients who survived to hospital discharge had a longer mean LOS compared to those who died during hospitalization (25.4 ± 22.03 days versus10.7 ± 1.74 days). In the multivariate analysis, increased age, intubation and increased lactate dehydrogenase (LDH) were each independently associated with increased odds of mortality. Diarrhea was associated with decreased mortality (OR 0.4; CI 0.16, 0.99). Obesity and use of vasopressors were each independently associated with increased intubation. In patients with COVID-19 disease and high oxygen requirements, advanced age, intubation, and higher LDH levels were associated with increased mortality, while diarrhea was associated with decreased mortality. Gender, diabetes, and hypertension did not have any association with mortality or length of hospital stay.
Sections du résumé
BACKGROUND
BACKGROUND
Approximately 19% of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) progress to severe or critical stages of the coronavirus disease 2019 (COVID-19) with a mortality rate exceeding 50%. We aimed to examine the characteristics, mortality rates, intubation rate, and length of stay (LOS) of patients hospitalized with COVID-19 disease with high oxygen requirements (critically ill).
METHODS
METHODS
We conducted a retrospective analysis in a single center in Brooklyn, New York. Adult hospitalized patients with confirmed COVID-19 disease and high oxygen requirements were included. We performed multivariate logistic regression analyses for statistically significant variables to reduce any confounding.
RESULTS
RESULTS
A total of 398 patients were identified between March 19th and April 25th, 2020 who met the inclusion criteria, of which 247 (62.1%) required intubation. The overall mortality rate in our study was 57.3% (n = 228). The mean hospital LOS was 19.1 ± 17.4 days. Patients who survived to hospital discharge had a longer mean LOS compared to those who died during hospitalization (25.4 ± 22.03 days versus10.7 ± 1.74 days). In the multivariate analysis, increased age, intubation and increased lactate dehydrogenase (LDH) were each independently associated with increased odds of mortality. Diarrhea was associated with decreased mortality (OR 0.4; CI 0.16, 0.99). Obesity and use of vasopressors were each independently associated with increased intubation.
CONCLUSIONS
CONCLUSIONS
In patients with COVID-19 disease and high oxygen requirements, advanced age, intubation, and higher LDH levels were associated with increased mortality, while diarrhea was associated with decreased mortality. Gender, diabetes, and hypertension did not have any association with mortality or length of hospital stay.
Identifiants
pubmed: 33613798
doi: 10.14740/jocmr4405
pmc: PMC7869563
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26-37Informations de copyright
Copyright 2021, Rojas-Marte et al.
Déclaration de conflit d'intérêts
None to declare.
Références
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1753-1759.e2
pubmed: 32311512
Crit Care. 2020 Jul 6;24(1):394
pubmed: 32631393
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
QJM. 2020 Aug 1;113(8):546-550
pubmed: 32569363
Trends Microbiol. 2013 Oct;21(10):544-55
pubmed: 23770275
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Diabetes Metab Res Rev. 2020 Jul 19;:e3388
pubmed: 32683744
Am J Emerg Med. 2020 Sep;38(9):1722-1726
pubmed: 32738466
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Int J Med Sci. 2020 May 18;17(9):1281-1292
pubmed: 32547323
BMJ Open Diabetes Res Care. 2020 Apr;8(1):
pubmed: 32345579
Dig Dis. 2020;38(5):373-379
pubmed: 32599601
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Gastroenterol Hepatol. 2020 Jun 29;:
pubmed: 32602128